ZLAB Q3 2022 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$58M+33.5% YoY

Gross Profit

$37M65.2% margin

Operating Income

-$129M-223.5% margin

Net Income

-$161M-280.1% margin

EPS (Diluted)

$-16.80

QoQ Revenue Growth

+19.4%

Cash Flow

Operating Cash Flow

-$126M

Free Cash Flow

-$133M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$193M

Stockholders' Equity

$1.1B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$43M	+33.5%
Gross Profit	$37M	-$24M	+254.9%
Operating Income	-$129M	-$83M	-54.5%
Net Income	-$161M	-$96M	-67.2%

Revenue Segments

Zejula

$39M69%

Optune

$11M19%

Qinlock

$6M10%

Nuzyra

$2M3%